Wells Fargo’s ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD RBS.PRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-46,168
Closed -$1.16M 6564
2016
Q2
$1.16M Buy
46,168
+4,711
+11% +$119K ﹤0.01% 3387
2016
Q1
$1.05M Buy
41,457
+1,283
+3% +$32.4K ﹤0.01% 3382
2015
Q4
$1.04M Sell
40,174
-17,990
-31% -$461K ﹤0.01% 3452
2015
Q3
$1.47M Sell
58,164
-48,468
-45% -$1.23M ﹤0.01% 3234
2015
Q2
$2.7M Buy
106,632
+52,532
+97% +$1.34M ﹤0.01% 2866
2015
Q1
$1.38M Buy
54,100
+1,876
+4% +$47.9K ﹤0.01% 3294
2014
Q4
$1.33M Sell
52,224
-2,776
-5% -$70.5K ﹤0.01% 3316
2014
Q3
$1.39M Buy
55,000
+3,717
+7% +$94.1K ﹤0.01% 3248
2014
Q2
$1.29M Buy
51,283
+2,732
+6% +$69.1K ﹤0.01% 3334
2014
Q1
$1.21M Sell
48,551
-34,525
-42% -$859K ﹤0.01% 3356
2013
Q4
$1.99M Buy
83,076
+41,511
+100% +$1,000K ﹤0.01% 2947
2013
Q3
$976K Sell
41,565
-4,733
-10% -$110K ﹤0.01% 3371
2013
Q2
$1.11M Buy
+46,298
New +$1.14M ﹤0.01% 3211

Wells Fargo's RBS.PRT Position: Q3 2016 in Review

Wells Fargo sold out of ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD (RBS.PRT) in Q3 2016, closing a stake of 46,168 shares — an estimated $1.16M sold.

Wells Fargo first reported a position in RBS.PRT in Q2 2013 and held it in 13 quarters. The position peaked at $2.7M in Q2 2015. 0 funds tracked by Wall St. Rank hold RBS.PRT as of Q3 2016.

  • Wells Fargo reported no remaining ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD position as of Q3 2016 after selling out during the quarter.
  • Wells Fargo sold 46,168 ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD shares in Q3 2016, an estimated $1.16M.
  • Wells Fargo first reported a position in ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD in Q2 2013 and held it in 13 quarters.
  • Wells Fargo's ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD position peaked at $2.7M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held ROYAL BANK OF SCOTLAND GRP PLS (THE) SPONS ADR REPSTG PFD as of Q3 2016.

Based on Wells Fargo's 13F filing for Q3 2016, filed 31 Oct 2016.